Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 2Unknown 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Small Cell Lung Carcinoma 1Ovarian Neoplasms 1Endometrial Neoplasms 1Breast Neoplasms 1Advanced Solid Tumor 1

Interventions

spartalizumab 3Injections 3toripalimab 2camrelizumab 2anlotinib 2Therapeutics 2Cisplatin 2Capecitabine 2tislelizumab 1pembrolizumab 1fludarabine 1donafenib 1Pemetrexed 1PM 01183 1Leucovorin 1Irinotecan 1Injections, Intravenous 1Gemcitabine 1Fluorouracil 1Cyclophosphamide 1Carboplatin 15'-Nucleotidase 1130-nm albumin-bound paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Advanced Solid Tumor × PM 01183 × Clear all
NCT05101265 2023-11-27

Clinical Pharmacokinetic Study of Lurbinectedin in Patients With Advanced Solid Tumors and Varying Degrees of Hepatic Impairment

PharmaMar

Phase 1 Unknown
24 enrolled
Other solid neoplasm

Advanced Solid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡